Serum concentrations of vascular endothelial growth factor in angiosarcomas with and without p53 gene mutation [1]

Acta Dermato-Venereologica

Volumn 82, Issue 5, 2002, Pages 373-374

  Amo, Yasuyuki ^a   Masuzawa, Mikio ^a   Hamada, Yuhko ^a   Katsuoka, Kensei ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; VASCULOTROPIN;

ADULT; AGED; ANGIOSARCOMA; CANCER INVASION; CELL PROLIFERATION; CLINICAL ARTICLE; ENDOTHELIUM CELL; FEMALE; GENE MUTATION; HUMAN; LETTER; MALE; MALIGNANT TRANSFORMATION; POINT MUTATION; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; ENDOTHELIAL GROWTH FACTORS; FEMALE; GENES, P53; HEMANGIOSARCOMA; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; MALE; MIDDLE AGED; MUTATION; POINT MUTATION; PROGNOSIS; PROSPECTIVE STUDIES; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036402287     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.1080/000155502320624122     Document Type: Letter

References (7)

1. Hashimoto M, Ohsawa M, Ohnishi A, Naka N, Hirota S, Kitamura Y, et al. Expression of vascular endothelial growth factor and its receptor mRNA in angiosarcoma. Lab Invest 1995; 73: 859-863.
2. Masood R, Cai J, Zheng T, Smith L, Naidu Y, Gill PS. Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-associated Kaposi's sarcoma. Proc Natl Acad Sci USA 1997; 94: 979-984.
3. Naka N, Tomita Y, Nakanishi H, Araki N, Hongyo T, Ochi T, et al. Mutation of p53 tumor-suppressor gene in angiosarcoma. Int J Cancer 1997; 71: 952-955.
4. Masuzawa M, Fujimura T, Hamada Y, Fujita Y, Hara H, Nishiyama S, et al. Establishment of a human hemangiosarcoma cell line (ISO-HAS). Int J Cancer 1999; 81: 305-308.
5. Amo Y, Masuzawa M, Hamada Y, Takasu H, Fujimura T, Katsuoka K, et al. Serum levels of vascular endothelial growth factor in a hemangiosarcoma patient with a new-typed p53 gene point mutation. Br J Dermatol 2000; 143: 1118-1119.
6. Amo Y, Masuzawa M, Hamada Y, Katsuoka K. Expression of vascular endothelial growth factor in a human hemangiosarcoma cell line (ISO-HAS). Arch Dermatol Res 2001; 293: 296-301.
7. Hollstein M, Sidransky D, Vogelstein B, Harris SR. p53 mutations in human cancers. Science 1991; 253: 49-53.